Pfizer Products Corporation New York City, NY - 10017

Pfizer Products Corporation is categorized under Drugs, Proprietaries, and Sundries in New York City, NY and active since 1986.

Pfizer Products Corporation was established in 1986, and today employs 1 to 4, earning Unknown per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Henry Mckinnell at the company’s single location by writing to 235 East 42nd St, New York City, New York NY 10017 or by phoning (530) 378-2607. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pfizer Products Corporation
Contact Person: Henry Mckinnell
Address: 235 East 42nd St, New York City, New York 10017
Phone Number: (530) 378-2607
Website Address: pfizer.com
Annual Revenue (USD): Unknown
Founded: 1986
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drugs, Proprietaries, and Sundries
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Pfizer Products Corporation was started in 1986 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Henry Mckinnell for inquiries that concern Pfizer Products Corporation by calling the company number (530) 378-2607, as your correspondence is most welcome. Additionally, the physical location of the single location of Pfizer Products Corporation can be found at the coordinates as well as the street address 235 East 42nd St in New York City, New York 10017.

For its online presence, you may visit Pfizer Products Corporation’s website at pfizer.com and engage with its social media outlets through on Twitter and on Facebook.